BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987
723 results:

  • 1. The mdm2-p53 Axis Represents a Therapeutic Vulnerability Unique to Glioma Stem cells.
    Nakagawa-Saito Y; Mitobe Y; Togashi K; Suzuki S; Sugai A; Takenouchi S; Nakamura K; Sonoda Y; Kitanaka C; Okada M
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612758
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Evolution of Testicular germ cell tumors in the Molecular Era With Histogenetic Implications.
    Kilic I; Acosta AM; Idrees MT
    Adv Anat Pathol; 2024 May; 31(3):206-214. PubMed ID: 38525515
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Glioblastoma Therapy: Past, Present and Future.
    Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The development of a custom RNA-sequencing panel for the identification of predictive and diagnostic biomarkers in glioma.
    Shirai Y; Ueno T; Kojima S; Ikeuchi H; Kitada R; Koyama T; Takahashi F; Takahashi K; Ichimura K; Yoshida A; Sugino H; Mano H; Narita Y; Takahashi M; Kohsaka S
    J Neurooncol; 2024 Mar; 167(1):75-88. PubMed ID: 38363490
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Bioinformatics analysis proposes a possible role for long noncoding RNA MIR17HG in retinoblastoma.
    Wang Z; Liang X; Yi G; Wu T; Sun Y; Zhang Z; Fu M
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1933. PubMed ID: 38321787
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Prognostic model for assessing the human glioma cell malignancy grade based on mdm2, MELK, SOX2, CDK4, DR5 and OCT4 gene expression.
    Tyagunova EE; Drozd SF; Kalennik OV; Samoylenkova NS; Savchenko EA; Danilov GV; Pavlova GV
    Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):43-51. PubMed ID: 38054226
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma.
    Tateishi K; Miyake Y; Nakamura T; Iwashita H; Hayashi T; Oshima A; Honma H; Hayashi H; Sugino K; Kato M; Satomi K; Fujii S; Komori T; Yamamoto T; Cahill DP; Wakimoto H
    Acta Neuropathol Commun; 2023 Nov; 11(1):186. PubMed ID: 38012788
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Assessment of The Utility of The Sarcoma DNA Methylation Classifier In Surgical Pathology.
    Miettinen M; Abdullaev Z; Turakulov R; Quezado M; Luiña Contreras A; Curcio CA; Rys J; Chlopek M; Lasota J; Aldape KD
    Am J Surg Pathol; 2024 Jan; 48(1):112-122. PubMed ID: 37921028
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Three-Dimensional Gene Regulation Network in Glioblastoma Ferroptosis.
    Liu M; Wang W; Zhang H; Bi J; Zhang B; Shi T; Su G; Zheng Y; Fan S; Huang X; Chen B; Song Y; Zhao Z; Shi J; Li P; Lu W; Zhang L
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834393
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Delivery versus Potency in Treating Brain tumors: BI-907828, a mdm2-p53 Antagonist with Limited BBB Penetration but Significant In Vivo Efficacy in Glioblastoma.
    Zhang W; Vaubel RA; Oh JH; Mladek AC; Talele S; Zhang W; Waller KL; Burgenske DM; Sarkaria JN; Elmquist WF
    Mol Cancer Ther; 2024 Jan; 23(1):47-55. PubMed ID: 37828724
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. USP7 Inhibition Suppresses Neuroblastoma Growth via Induction of p53-Mediated Apoptosis and EZH2 and N-Myc Downregulation.
    Le Clorennec C; Lee K; Huo Y; Zage PE
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762082
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG.
    Miranda J; Vázquez-Blomquist D; Bringas R; Fernandez-de-Cossio J; Palenzuela D; Novoa LI; Bello-Rivero I
    BMC Cancer; 2023 Aug; 23(1):806. PubMed ID: 37644431
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Competing Engagement of β-arrestin Isoforms Balances IGF1R/p53 Signaling and Controls Melanoma cell Chemotherapeutic Responsiveness.
    Cismas S; Pasca S; Crudden C; Trocoli Drakensjo I; Suleymanova N; Zhang S; Gebhard B; Song D; Neo S; Shibano T; Smith TJ; Calin GA; Girnita A; Girnita L
    Mol Cancer Res; 2023 Dec; 21(12):1288-1302. PubMed ID: 37584671
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Nuclear transport surveillance of p53 by nuclear pores in glioblastoma.
    Ikliptikawati DK; Hirai N; Makiyama K; Sabit H; Kinoshita M; Matsumoto K; Lim K; Meguro-Horike M; Horike SI; Hazawa M; Nakada M; Wong RW
    Cell Rep; 2023 Aug; 42(8):112882. PubMed ID: 37552992
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. GSG2 facilitates the progression of human breast cancer through mdm2-mediated ubiquitination of E2F1.
    Tang Y; Dai G; Yang Y; Liu H
    J Transl Med; 2023 Aug; 21(1):523. PubMed ID: 37537694
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.
    Meredith DM; Cooley LD; Dubuc A; Morrissette J; Sussman RT; Nasrallah MP; Rathbun P; Yap KL; Wadhwani N; Bao L; Wolff DJ; Ida C; Sukhanova M; Horbinski C; Jennings LJ; Farooqi M; Gener M; Ginn K; Kam KL; Sasaki K; Kanagal-Shamanna R; Alexandrescu S; Brat D; Lu X
    Mod Pathol; 2023 Nov; 36(11):100294. PubMed ID: 37532182
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. P53 status, and G2/M cell cycle arrest, are determining factors in cell-death induction mediated by ELF-EMF in glioblastoma.
    Mehdizadeh R; Madjid Ansari A; Forouzesh F; Shahriari F; Shariatpanahi SP; Salaritabar A; Javidi MA
    Sci Rep; 2023 Jul; 13(1):10845. PubMed ID: 37407632
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. miR-3174 Is a New tumor Suppressor MicroRNA That Inhibits Several tumor-Promoting Genes in Glioblastoma.
    Hanif F; Zhang Y; Dube C; Gibert MK; Saha S; Hudson K; Marcinkiewicz P; Kefas B; Guessous F; Abounader R
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298284
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Molecular and Functional Heterogeneity of Primary Pancreatic Neuroendocrine tumors and Metastases.
    Guo Y; Tian C; Cheng Z; Chen R; Li Y; Su F; Shi Y; Tan H
    Neuroendocrinology; 2023; 113(9):943-956. PubMed ID: 37232011
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Single-cell molecular profiling using ex vivo functional readouts fuels precision oncology in glioblastoma.
    Panovska D; Nazari P; Cole B; Creemers PJ; Derweduwe M; Solie L; Van Gassen S; Claeys A; Verbeke T; Cohen EF; Tolstorukov MY; Saeys Y; Van der Planken D; Bosisio FM; Put E; Bamps S; Clement PM; Verfaillie M; Sciot R; Ligon KL; De Vleeschouwer S; Antoranz A; De Smet F
    Cell Mol Life Sci; 2023 May; 80(6):147. PubMed ID: 37171617
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 37.